The majority of ICCR Datasets scheduled to be developed will be in response to updates of the World Health Organization (WHO) Classification of Tumours or applicable staging system. However, additional datasets are scheduled where there are specific needs to be addressed and resources available.
The WHO Classification of Tumours ‘Blue book’ revisions for Endocrine neoplasms is underway and the ICCR has therefore commenced development for a series of four datasets in this area:
Public consultation is expected in the second quarter of 2019.
- Adrenal cortical gland
- Phaeochromoctyoma and paraganglioma
The WHO Classification of Tumours ‘Blue book’ revisions for Skin neoplasms is now published and the ICCR has therefore commenced an update to the Invasive cutaneous melanoma dataset as well as the development of a new dataset for the reporting of Merkel Cell Carcinoma.
The ICCR has commenced development of a series of five datasets for the digestive tract:
- Exocrine pancreas
The ICCR has commenced development of a series of three datasets for breast:
- Invasive breast cancer
- Ductal carcinoma in situ (DCIS)
- Lymph node dissection/sentinel node biopsy
With the release of the 8th edition of TNM staging, impacted ICCR datasets have been updated - Lung, Endometrial, Thymic and Mesothelioma and posted to the website. Invasive cutaneous melanoma still requires an update to TNM8 and this will be undertaken in 2018 as part of the development of the Skin suite of datasets.